欧康维视生物-B 港股通 空最新增减持 (2026-06-26) 官网 ( 01477.hk) | -29.39 | 1.27 | 0% | 上市时间2020-07-10股价6.21港币涨跌幅0.98%成交金额1,318.68万港币换手率0.26%市值51.94亿港币H股市值51.94亿港币总股本8.36亿H股本8.36亿每手股数500上市至今年化投资收益率-25.38%港股通持仓占H股比例6.91% (3.24亿港币2026-07-17) 累计做空占H股比例2.57% (1.09亿港币2026-07-10) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 121.76 | 市净率 | 4.44 | 股息率 | 0.38% | 恒生:医疗保健业药品及生物科技生物技术 |
| 备注 (3): | 双击编辑备注 |
欧康维视生物-B(01477) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 張振宇 | Independent Non Executive Director | 2022-04-08 | -- | |
| 2 | 陳連勇 | Non Executive Director | 2021-07-20 | -- | |
| 3 | 李偉 | Non Executive Director | 2021-07-20 | -- | |
| 4 | 王雨濛 | Non Executive Director | 2021-03-19 | -- | |
| 5 | 黃翼然 | Independent Non Executive Director | 2020-06-23 | -- | |
| 6 | 胡定旭 | Independent Non Executive Director - A/F | 2020-06-23 | -- | |
| 7 | 何連明 | Independent Non Executive Director | 2020-06-23 | 2022-03-30 | |
| 8 | 胡兆鵬 | Executive Director | 2020-04-24 | -- | |
| 9 | 孫樂非 | Non Executive Director | 2020-04-24 | 2021-03-19 | |
| 10 | 曹彥凌 | Non Executive Director | 2019-06-18 | -- | |
| 11 | 劉曄 | Executive Director | CEO | 2018-11-23 | -- |
| 12 | 陳連勇 | Executive Director | Chairman | 2018-05-23 | 2021-07-20 |
| 13 | 李偉 | Executive Director | 2018-04-13 | 2021-07-20 |